Kenvue's Kimberly-Clark Deal Nears Closing With Key Risks Still Ahead

KVUE shareholders approved the planned Q4 2026 combination with KMB, and the deal has cleared U.S. antitrust review. But execution risks are stacking up: KVUE carries an $8.5 billion debt burden, Q2 adjusted gross margin fell 70 basis points, and the Self Care segment continues to underperform. Q2 sales grew 3%, yet earnings per share missed analyst estimates. The combined entity will face margin pressure from inflation and tariffs, along with restructuring costs and pending litigation.

The merger timeline extends nearly two years, leaving ample room for macro headwinds or operational missteps to erode the deal's strategic rationale. KVUE's margin compression and debt load complicate the integration math, particularly if cost synergies take longer to materialize than anticipated.